Shp2 signaling suppresses senescence in PyMT‐induced mammary gland cancer in mice

By  

THE EMBO JOURNAL, Vol. 34, Iss. 11, 2015-06 ,pp. : 1493-1508

John Wiley & Sons Inc

Access to resources Recommend Favorite

SHP2: a new target for pro‐senescence cancer therapies

By  

THE EMBO JOURNAL, Vol. 34, Iss. 11, 2015-06 ,pp. : 1439-1441

John Wiley & Sons Inc

Access to resources Recommend Favorite

Runx1 is associated with breast cancer progression in MMTV‐PyMT transgenic mice and its depletion in vitro inhibits migration and invasion

By  

JOURNAL OF CELLULAR PHYSIOLOGY, Vol. 230, Iss. 10, 2015-10 ,pp. : 2522-2532

John Wiley & Sons Inc

Access to resources Recommend Favorite

Shp2 Plays a Critical Role in IL-6-Induced EMT in Breast Cancer Cells

By Sun Xuan   Zhang Jie   Wang Zhiyong   Ji Wei   Tian Ran   Zhang Fei   Niu Ruifang  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-02 ,pp. : 395-395

MDPI

Access to resources Recommend Favorite

Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric Cancer

By Wu Cheng-Shyong   Wei Kuo-Liang   Chou Jian-Liang   Lu Chung-Kuang   Hsieh Ching-Chuan   Lin Jora M. J.   Deng Yi-Fang   Hsu Wan-Ting   Wang Hui-Min David   Leung Chung-Hang   Ma Dik-Lung   Li Chin   Chan Michael W. Y.  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1467-1467

MDPI

Access to resources Recommend Favorite